Astellas Pharma Inc
(FRA:YPHA)
€
12.7
+0.50 (+4.1%)
Market Cap: 22.75 Bil
Enterprise Value: 24.58 Bil
PE Ratio: 11.64
PB Ratio: 2.18
GF Score: 75/100 Full Year 2025 Astellas Pharma Inc Earnings Presentation Transcript
Apr 25, 2025 / 08:00AM GMT
Release Date Price:
€8.15
(-2.98%)
Hiromitsu Ikeda
Astellas Pharma Inc - Chief Communications & Investor Relations Officer
Thank you very
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot